Mauricio M Rodrigues
Overview
Explore the profile of Mauricio M Rodrigues including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
2131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moraschi B, Noronha I, Ferreira C, Cariste L, Monteiro C, Denapoli P, et al.
Front Cell Infect Microbiol
. 2021 Jun;
11:676183.
PMID: 34123875
Deficiency in memory formation and increased immunosenescence are pivotal features of infection proposed to play a role in parasite persistence and disease development. The vaccination protocol that consists in a...
2.
de Camargo T, Freitas E, Gimenez A, Lima L, de Almeida Caramico K, Francoso K, et al.
Sci Rep
. 2018 Jan;
8(1):1118.
PMID: 29348479
Vaccine development against Plasmodium vivax malaria lags behind that for Plasmodium falciparum. To narrow this gap, we administered recombinant antigens based on P. vivax circumsporozoite protein (CSP) to mice. We...
3.
Clemente T, Vieira N, Cerliani J, Adrain C, Luthi A, Dominguez M, et al.
Cell Death Dis
. 2017 Dec;
8(12):e3176.
PMID: 29215607
Secretory granules released by cytotoxic T lymphocytes (CTLs) are powerful weapons against intracellular microbes and tumor cells. Despite significant progress, there is still limited information on the molecular mechanisms implicated...
4.
Gimenez A, Lima L, Francoso K, Denapoli P, Panatieri R, Bargieri D, et al.
Front Immunol
. 2017 Oct;
8:1275.
PMID: 29075260
is the most common species that cause malaria outside of the African continent. The development of an efficacious vaccine would contribute greatly to control malaria. Recently, using bacterial and adenoviral...
5.
Rocha M, Francoso K, Lima L, Camargo T, Machado R, Costa F, et al.
Vaccine
. 2017 Mar;
35(18):2463-2472.
PMID: 28341111
Plasmodium vivax is the most widely distributed malaria species and the most prevalent species of malaria in America and Asia. Vaccine development against P. vivax is considered a priority in...
6.
Amorim K, Rampazo E, Antonialli R, Yamamoto M, Rodrigues M, Soares I, et al.
Sci Rep
. 2016 Dec;
6():39250.
PMID: 28000705
In vivo antigen targeting to dendritic cells (DCs) has been used as a way to improve immune responses. Targeting is accomplished with the use of monoclonal antibodies (mAbs) to receptors...
7.
Gimenez A, Francoso K, Ersching J, Icimoto M, Oliveira V, Rodriguez A, et al.
Parasit Vectors
. 2016 Nov;
9(1):577.
PMID: 27842609
Background: Babesia bovis is a tick-transmitted protozoan hemoparasite and the causative agent of bovine babesiosis, a potential risk to more than 500 million cattle worldwide. The vaccines currently available are...
8.
Ersching J, Basso A, Calich V, Bortoluci K, Rodrigues M
PLoS Pathog
. 2016 Jul;
12(7):e1005771.
PMID: 27399890
[This corrects the article DOI: 10.1371/journal.ppat.1005698.].
9.
Ersching J, Basso A, Kalich V, Bortoluci K, Rodrigues M
PLoS Pathog
. 2016 Jun;
12(6):e1005698.
PMID: 27332899
Although CD4+ Foxp3+ T cells are largely described in the regulation of CD4+ T cell responses, their role in the suppression of CD8+ T cell priming is much less clear....
10.
Ersching J, Vasconcelos J, Ferreira C, Caetano B, Machado A, Bruna-Romero O, et al.
PLoS Pathog
. 2016 Apr;
12(4):e1005593.
PMID: 27128676
The β1i, β2i and β5i immunoproteasome subunits have an important role in defining the repertoire of MHC class I-restricted epitopes. However, the impact of combined deficiency of the three immunoproteasome...